Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aleisha Miller"'
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionOptimise:MS is an observational pharmacovigilance study aimed at characterizing the safety profile of disease-modifying therapies (DMTs) for multiple sclerosis (MS) in a real world population. The study will categorize and quantify the oc
Externí odkaz:
https://doaj.org/article/9a6f6585f2ef4c619a39c70cb2fde28a
Autor:
Ana Cavey, Ruth Dobson, Camilla Blain, Richard Nicholas, Jeremy Hobart, David Rog, Monica Marta, Cheryl Hemingway, Nikos Evangelou, Matthew Craner, Paul M Matthews, Neil Scolding, Helen L Ford, Stewart Webb, Ed Waddingham, Aleisha Miller, Carolyn Anne Young
Publikováno v:
BMJ Open, Vol 11, Iss 11 (2021)
Introduction The power of ‘real world’ data to improve our understanding of the clinical aspects of multiple sclerosis (MS) is starting to be realised. Disease modifying therapy (DMT) use across the UK is driven by national prescribing guidelines
Externí odkaz:
https://doaj.org/article/eea28e7dd903494f945fd089a3d7dcf3
Autor:
Steve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, Liesbet M. Peeters, Lotte Geys, Tina Parciak, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, Tim Spelman, Sifat Sharmin, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Bruce Bebo, Anneke van der Walt, Helmut Butzkueven, Serkan Ozakbas, Rana Karabudak, Cavit Boz, Raed Alroughani, Juan I Rojas, Ingrid van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo Alonso, Richard Nicholas, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Tomas Kalincik
Publikováno v:
Multiple sclerosis and related disorders. 66
Interferon-β, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS.Among 5,568 patients (83.4% confirmed COVID-19), interferon-treated patients had lower risk of severe COVID-19 compared to untreate
Autor:
Ruth Dobson, Matthew Craner, Ed Waddingham, Aleisha Miller, Jayant Pindoria, Ana Cavey, Camilla Blain, Gabriele De Luca, Nikos Evangelou, Helen Ford, Paul Gallagher, Katila George, Ruth Geraldes Ramos Dias, Paula Harman, Jeremy Hobart, Tanya King, Ruth Linighan, Niall MacDougall, Monica Marta, Stephanie Mitchell, Richard Nicholas, David Rog, Antonio Scalfari, Neil Scolding, Stewart Webb, Sarah White, Judith Wilton, Carolyn Young, Paul M Matthews
Publikováno v:
Multiple sclerosis and related disorders. 63
Clinical trial populations do not fully reflect routine practice. The power of routinely collected data to inform clinical practice is increasingly recognised.The OPTIMISE:MS pharmacovigilance study is a prospective, pragmatic observational study, co
Autor:
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, Edward De Brouwer, Lotte Geys, Tina Parciak, Anne Helme, Nick Rijke, Jan A. Hillert, Yves Moreau, Gilles Edan, Sifat Sharmin, Tim Spelman, Robert McBurney, Hollie Schmidt, Arnfin B. Bergmann, Stefan Braune, Alexander Stahmann, Rod M. Middleton, Amber Salter, Bruce Bebo, Anneke Van der Walt, Helmut Butzkueven, Serkan Ozakbas, Cavit Boz, Rana Karabudak, Raed Alroughani, Juan I. Rojas, Ingrid A. van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo N. Alonso, Richard S. Nicholas, Anibal S. Chertcoff, Ana Zabalza de Torres, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Liesbet M. Peeters
Publikováno v:
Simpson-Yap, S, Pirmani, A, Kalincik, T, De Brouwer, E, Geys, L, Parciak, T, Helme, A, Rijke, N, Hillert, J A, Moreau, Y, Edan, G, Sharmin, S, Spelman, T, McBurney, R, Schmidt, H, Bergmann, A B, Braune, S, Stahmann, A, Middleton, R M, Salter, A, Bebo, B, Van der Walt, A, Butzkueven, H, Ozakbas, S, Boz, C, Karabudak, R, Alroughani, R, Rojas, J I, van der Mei, I A, Sciascia do Olival, G, Magyari, M, Alonso, R N, Nicholas, R S, Chertcoff, A S, de Torres, A Z, Arrambide, G, Nag, N, Descamps, A, Costers, L, Dobson, R, Miller, A, Rodrigues, P, Prčkovska, V, Comi, G & Peeters, L M 2022, ' Updated Results of the COVID-19 in MS Global Data Sharing Initiative : Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity ', Neurology(R) neuroimmunology & neuroinflammation, vol. 9, no. 6 . https://doi.org/10.1212/NXI.0000000000200021
Scientia
Scientia
Background and Objectives Certain demographic and clinical characteristics, including the use of some disease-modifying therapies (DMTs), are associated with severe acute respiratory syndrome coronavirus 2 infection severity in people with multiple s
Autor:
Hannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, Sue Fleck, Aleisha Miller, Tom Cole, Nelson Sousa-Santos, Alethea Cope, Deniz Cizmeci, Monica Tolazzi, Edith Hwekwete, Drew Hannaman, Sven Kratochvil, Paul Francis McKay, Amy W. Chung, Stephen J. Kent, Adrian Cook, Gabriella Scarlatti, Sonya Abraham, Behazine Combadiere, Sheena McCormack, David John Lewis, Robin John Shattock
Publikováno v:
Human Gene Therapy
Human Gene Therapy, Mary Ann Liebert, 2018, 29 (9), pp.1011-1028. ⟨10.1089/hum.2018.075⟩
Human Gene Therapy, Mary Ann Liebert, 2018, 29 (9), pp.1011-1028. ⟨10.1089/hum.2018.075⟩
International audience; Intradermal (i.d.) and intramuscular (i.m.) injections when administered with or without electroporation (EP) have the potential to tailor the immune response to DNA vaccination. This Phase I randomized controlled clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5b609fe0bbabee74087e63ccb8b75dee
https://hal.sorbonne-universite.fr/hal-02173181/file/hum.2018.075.pdf
https://hal.sorbonne-universite.fr/hal-02173181/file/hum.2018.075.pdf